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Abstract
Objectives:Psychosocial factors havebeenhypothesized to increase the risk of cancer.
This study aims (1) to test whether psychosocial factors (depression, anxiety, recent
loss events, subjective social support, relationship status, general distress, and neu-
roticism) are associated with the incidence of any cancer (any, breast, lung, prostate,
colorectal, smoking-related, and alcohol-related); (2) to test the interaction between
psychosocial factors and factors related to cancer risk (smoking, alcohol use, weight,
physical activity, sedentary behavior, sleep, age, sex, education, hormone replacement
therapy, and menopausal status) with regard to the incidence of cancer; and (3) to test
the mediating role of health behaviors (smoking, alcohol use, weight, physical activity,
sedentary behavior, and sleep) in the relationship between psychosocial factors and
the incidence of cancer.
Methods: The psychosocial factors and cancer incidence (PSY-CA) consortium was
established involving experts in the field of (psycho-)oncology, methodology, and epi-
demiology. Using data collected in 18 cohorts (N = 617,355), a preplanned two-stage
individual participant data (IPD) meta-analysis is proposed. Standardized analyses will
be conducted on harmonized datasets for each cohort (stage 1), andmeta-analyseswill
be performed on the risk estimates (stage 2).
Conclusion: PSY-CA aims to elucidate the relationship between psychosocial factors
and cancer risk by addressing several shortcomings of prior meta-analyses.
KEYWORDS
cancer risk, depression, health behaviors, meta-analysis, psycho-oncology
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1 INTRODUCTION
Psychosocial factors such as depression, general distress, and low
social support have long been theorized to increase cancer risk (Dalton
et al., 2002). Findings from prior research studying the association
between psychosocial factors and cancer are mixed. Two meta-
analyses focusing on depression concluded that there was a small,
potentially trivial, effect on cancer risk (McGee et al., 1994; Oerle-
mans et al., 2007). Another meta-analysis of the published literature
indicated that depression (combined hazards ratio [HR] = 1.29), psy-
chosocial factors relating to stress-prone personality or poor coping
style (combined HR = 1.08), and psychosocial factors relating to emo-
tional distress or poor quality of life (combined HR = 1.13) increased
the risk for all cancer outcomes and, when collapsing psychosocial fac-
tors across subtypes, especially for lung cancer (combined HR = 1.23)
(Chida et al., 2008). However, the included studies varied greatly
in the psychosocial factors investigated and the cancer endpoint of
interest. It is crucial to use clearly and specifically defined psychosocial
factors as they can lead to distinct physiological and behavioral effects
(O’Donovan et al., 2010). These effects may increase risk for specific
cancers given their unique etiologies. Furthermore, published studies
vary greatly in the confounders adjusted for (if any), making reliability
and interpretation of outcome debatable. Rather than including
studies where analyses have been determined by the original authors,
two-stage individual participant data (IPD) meta-analysis refers to
the (re-)analysis of original data for each cohort using a standardized
approach (stage 1) before combining in a meta-analysis (stage 2)
(Tierney et al., 2020). IPD meta-analyses of cohorts have the potential
to produce more reliable results than meta-analyses of published
findings (Stewart & Parmar, 1993) as one can ensure a consistent
definition of the psychosocial factors, specific cancer endpoints, and
key confounders adjusted for across all included cohorts.
Evidence remains limited regarding how psychosocial factors
increase cancer risk. Theory postulates several possible, potentially
interrelated, pathways that link psychosocial factors and cancer,
including angiogenesis, endocrine mechanisms, immunosuppression,
impairments in DNA repair, and inflammation (Lutgendorf et al., 2007).
While health behaviors as a potential pathway between psychosocial
factors and cancer have received little attention, they deserve consid-
eration given the established relationship between health behaviors
and psychosocial factors (Strine et al., 2008; Verger et al., 2009), and
between health behaviors and cancer (Biswas et al., 2015; Chen et al.,
2018; Kerr et al., 2017). To date, studies have most often considered
health behaviors as confounders, rather than playing a direct role in
the association between psychosocial factors and cancer risk. If health
behaviors explain the relationship between psychosocial factors and
cancer risk, this may justify offering health behavior interventions in
at-risk groups such as individuals who are depressed and smoke.
The effects of psychosocial factors on cancer development may
depend on the presence or absence of health behaviors, somatic fac-
tors or demographic factors. If both psychosocial factors and health
behaviors or somatic factors play a causal role in cancer development,
they may interact with each other. If there is interaction, the presence
of both factors puts a person at a higher risk for cancer than what
would be expected based on the sum of the risk of each factor alone.
This may be the case when psychosocial factors and health behaviors
or somatic factors affect cancer development via the same or interre-
latedpathways. Factorswhichhavebeen related to cancer risk andmay
interact with psychosocial factors include smoking (Knekt et al., 1998),
weight (Kerr et al., 2017), alcohol use (Pelucchi et al., 2011), physical
activity (Kerr et al., 2017), sedentary behavior (Kerr et al., 2017), sleep
duration and sleep quality (Hurley et al., 2015), menopausal status (Tri-
chopoulos et al., 1972), hormone replacement therapy (Vecchia et al.,
2001), age (Thakkar et al., 2014), sex (White et al., 2018), and educa-
tion level (Mouw et al., 2008). For example, in one study, depressive
symptoms increased the risk of colorectal cancer particularly in over-
weightwomen (Kroenke et al., 2005), and another study found that the
effect of depressive symptoms on cancer risk was increased at higher
levels of cigarette smoking (Linkins &Comstock, 1990). Studying inter-
actions provides insight into the mechanisms leading to cancer devel-
opment and also shows for which subgroups the association between
psychosocial factors and cancer incidence is most prominent and thus
could benefit most from preventive interventions.
Health behaviors may not only interact with psychosocial fac-
tors, but may also function as mediators situated in the pathway
from psychosocial factors to the development of cancer. Symptoms
of depression, for example, have been linked to smoking initiation
and the amount of smoking (Steuber & Danner, 2006), increased
alcohol use (Bulloch et al., 2012), weight gain, weight loss, obesity
(Blaine, 2008), decreased physical activity (Roshanaei-Moghaddam
et al., 2009), increased sedentary behavior (Roshanaei-Moghaddam
et al., 2009), and sleep disturbances (Benca et al., 1997), all of which
have subsequently been associated with an increased cancer risk
(Biswas et al., 2015; Chen et al., 2018; Kerr et al., 2017). While weight
is not a health behavior, we refer to this as a health behavior given the
association with several other health behaviors, specifically diet and
physical activity. Despite numerous allusions to the potential mediat-
ing role of health behaviors in the relationship between psychosocial
factors and cancer (Chida et al., 2008; Dalton et al., 2002), there are
remarkably few studies in which this has been tested.
The psychosocial factors and cancer incidence (PSY-CA) consortium
was established to investigate whether a variety of psychosocial fac-
tors increase the risk of cancer. The investigated psychosocial factors
include diagnosed depressive disorder and depressive symptoms (Jia
et al., 2017) (here forth referred to as depression), diagnosed anxiety
disorder and anxiety symptoms (Chen et al., 2018) (here forth referred
to as anxiety), (recent) loss events (Dalton et al., 2002), perceived
low social support (Idahl et al., 2018), relationship status (Randi et al.,
2004), general distress (Peled et al., 2008), and neuroticism (Schapiro
et al., 2001). The cancer endpoints include any cancer and the four
most prevalent cancers worldwide (excluding nonmelanoma skin can-
cer): breast cancer, lung cancer, prostate cancer, and colorectal can-
cer. We also categorize cancers for which common causal factors are
known, namely: smoking-related cancers and alcohol-related cancers,
as psychosocial factors may increase smoking and alcohol use (Strine
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F IGURE 1 The threemodels that are researched in psychosocial factors and cancer incidence (PSY-CA): (1) the longitudinal association
between psychosocial factors and cancer incidence, (2) the interaction between psychosocial factors and health behaviors, somatic factors, and
demographic factors in cancer incidence, and (3) themediating role of health behaviors in the longitudinal association between psychosocial
factors and cancer incidence
et al., 2008; Verger et al., 2009), thereby increasing risk for these can-
cers. The goals of the PSY-CA consortium are (1) to test whether psy-
chosocial factors (depression, anxiety, recent loss events, subjective
social support, relationship status, general distress, and neuroticism)
are associated with the incidence of any cancer (breast, lung, prostate,
colorectal, smoking-related cancer, and alcohol-related cancer); (2) to
test the interaction between psychosocial factors and factors related
to cancer risk (smoking, alcohol use,weight, physical activity, sedentary
behavior, sleep, age, sex, education, hormone replacement therapy, and
menopausal status) in the incidence of cancer; (3) to test themediating
role of health behaviors (smoking, alcohol use, weight, physical activity,
sedentary behavior, and sleep) in the relationship between psychoso-
cial factors and the incidence of cancer (see Figure 1). Specific hypothe-
ses have been formulated (Appendix 1).
2 METHODS
2.1 Design overview
Preplanned two-stage IPDmeta-analyses are performed.We apply the
Maelstrom guidelines (Fortier et al., 2016) to create harmonized vari-
ables across the 18 cohorts. Data are analyzed in each cohort (stage 1)
and the outputs are used in ameta-analysis (stage 2).
2.2 PSY-CA consortium
The consortium consists of the steering group (LvT, JD, AV, AdG, and
AVR), three main researchers (LvT, MB, and K-YP), representatives
from each participating cohort, and selected experts in the field of
psycho-oncology, epidemiology, methodology, and statistics. Meetings
areheld at least two times ayearwith the first formal consortiummeet-
ing having taken place onMarch 2019. During themeetings, consensus
is reached on the objectives, approach, and interpretation of findings.
The project leader (JD), the steering group, and the representatives of
the Dutch cohorts are responsible for the formal management of the
study.
2.3 Preregistration
The PSY-CA study has been preregistered in PROSPERO:
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https://www.crd.york.ac.uk/prospero/display_record.php?
ID = CRD42020157677 (study aim 1), https://www.crd.york.ac.
uk/prospero/display_record.php?ID = CRD42020181623 (study aim
2), and https://www.crd.york.ac.uk/prospero/display_record.php?
ID=CRD42020193716 (study aim 3).
2.4 Ethics
The ethics approval for PSY-CA was waived by the Medical Ethics
Review Committee of VU University Medical Center (2018.101). For
inclusion in PSY-CA, ethics approval was granted for each study by the
local institution or through appropriate national research governance
frameworks.
2.5 Inclusion/exclusion criteria
2.5.1 Cohorts
Cohorts were eligible to take part in PSY-CA if following criteria were
met:
1. a valid and reliable measure of depression, anxiety, recent loss
events, social support, general distress, and/or neuroticism;
2. availability of an objective measure of cancer diagnosis during
follow-upor the potential to get this information through, for exam-
ple, linkage with a cancer registry;
3. availability of data regarding smoking, alcohol, sex, and age; and
4. aprospective studydesign (i.e., psychosocial factorsweremeasured
before cancer incidence).
Cohorts were not eligible if there was no information about a his-
tory of cancer at baseline. Initially, relatively objective social support
(i.e., social network size) and hopelessnesswere concepts also included
in the first criterion, however as most cohorts did not have a mea-
sure of this, these concepts were subsequently dropped. Objective
social support was replaced with relationship status. One cohort—
Prospect-EPIC (see Table 1)—initially appeared to have information
about depression and anxiety diagnoses through a psychiatric registry.
However, on closer inspection, this data appeared to be incomplete.
As relationship status was measured in Prospect-EPIC, it remained
included in the study.
2.5.2 Participants
Across all analyses, participants were excluded if they had a cancer
diagnosis (based on [cancer] registry data or self-report) at baseline
or in the past (including in situ carcinomas and neoplasms of undeter-
mined behavior [i.e., benign/malignant status undetermined]), with the
exception of nonmelanoma skin cancer. Participants who had refused
linkage with an external registry were also excluded from any analy-
sis. People with a cancer diagnosis within one year from baseline were
excluded from the analysis.
2.6 Search strategy and eligible studies
In preparation of PSY-CA, a feasibility study was conducted to iden-
tify potential cohorts (December 2015 toMarch 2017). An extensive
search for all relevant Dutch cohorts was conducted using the net-
work of experts participating in PSY-CA. The coordinators of these
cohorts were approached and invited to take part in PSY-CA. In order
to increase the number of cohorts, international cohorts that fulfilled
the inclusion criteria were identified through the BioShare consortium
(which is now linked to the Public Population Project in Genomics and
Society) (http://www.p3gconsortium.org/about-p3g), IntegrativeAnal-
ysis of Longitudinal Studies ofAging network (www.ialsa.org/). Consor-
tium members were also asked if they knew of the existence of any
international cohorts that met the inclusion criteria. In addition, a lit-
erature reviewwas conducted in preparation of the feasibility study.
During the feasibility study, coordinators of the candidate cohorts
were contacted to check whether the inclusion and exclusion criteria
were met, and to outline any other potential issues related to costs
or ethical issues, for example. The included cohorts (11 cohorts in the
Netherlands and seven cohorts in the United Kingdom, Norway, and
Canada) are outlined in Table 1.
PSY-CA is set up in such a way that after the project has finished,
additional cohorts can be incorporated by applying the harmonization
manual (outlined in data handling below) to the data and running the
standardized analyses scripts.
2.7 Variables
2.7.1 Psychosocial factors
The relationship between the following seven psychosocial factors and
cancer incidence is analyzed: depressive symptoms or clinical depres-
sion (i.e., major depressive disorder, dysthymia), anxiety symptoms
or anxiety disorders (excluding specific phobias), recent loss events
(defined specifically as the loss of an immediate familymember or part-
ner in the last 12 months), perceived social support, relationship sta-
tus, general distress (specified as scored on the Mental Health Inven-
tory of the Short-form health survey (SF-36) or the RAND36 (Ware &
Sherbourne, 1992)), andneuroticism.Only validatedorpreviously pub-
lishedmeasures of the psychosocial factors are used.
2.7.2 Cancer
The primary outcomes in PSY-CAare incidence of all cancers, smoking-
and alcohol-related cancers, and the four most prevalent cancers in
the Netherlands: breast cancer (females only), colorectal cancer, lung
cancer, and prostate cancer (males only). Cancers were classified as
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TABLE 1 Overview cohorts participating in the psychosocial factors and cancer incidence (PSY-CA) study
Name of Cohort
Number of
subcohorts
includedb
Organizations
(country)
Number of
participantsa
Approx. max
follow-up
duration
(years) for
cancer
diagnosis Reference
Ontario Health Study 1 University of Toronto
(Canada)
163,257 10 (Borugian et al., 2010;
Dummer et al., 2018)
Lifelines 1 UniversityMedical
Center Groningen
(The Netherlands)
152,000 13 (Scholtens et al., 2015)
Nord-Trøndelag Health
Study (HUNT)
2 Norwegian University
of Science and
Technology (Norway)
62,237 13–24 (Krokstad et al., 2013)
CARTaGENE 1 Centre Hospitalier
Universitaire Sainte
Justine (Canada)
43,000 10 (Awadalla et al., 2013;
Borugian et al., 2010;
Dummer et al., 2018)
Atlantic PATH 1 Dalhousie University
(Canada)
34,169 10 (Borugian et al. 2010;
Sweeney et al., 2017)
European Prospective
Investigation into Cancer
andNutrition
(MORGEN-EPIC)
1 National Institute for
Public Health and the
Environment (RIVM)
(The Netherlands)
23,100 24 (Beulens et al., 2010;
Riboli, 1992, 2002)
Healthy Life in an Urban
Setting (HELIUS)
1 AmsterdamUniversity
Medical Centers and
Amsterdam
Municipal Health
Service (The
Netherlands)
19,932 8 (Snijder et al., 2017;
Stronks et al., 2013)
European Prospective
Investigation into Cancer
andNutrition
(Prospect-EPIC)
1 UniversityMedical
Center Utrecht (The
Netherlands)
17,357 24 (Beulens et al., 2010;
Boker et al., 2001;
Riboli, 1992, 2002)
Dutch occupational and
Environmental Health
Cohort Study (AMIGO)
1 Utrecht University (The
Netherlands)
14,829 5 (Slottje et al., 2014)
Avon Longitudinal Study of
Parents and Children
(ALSPAC)
1 University of Bristol
(England)
14,541 20 (Fraser et al., 2013)
SecondManifestations of
ARTerial disease
(SMART)
1 UniversityMedical
Center Utrecht (The
Netherlands)
11,881 12 (Simons et al., 1999)
Rotterdam Study 3 ErasmusMCUniversity
Medical Center (The
Netherlands)
11,740 8–14 (Hofman et al., 2015)
English Longitudinal Study
of Ageing (ELSA)
1 University College
London (England)
11,391 14 (Steptoe et al., 2013)
Whitehall-II study (WH-II) 1 University College
London (England)
10,308 11 (Marmot & Brunner,
2005)
OMEGA-II 1 TheNetherlands
Cancer Institute (The
Netherlands)
10,000 8 (van den Belt-Dusebout
et al., 2016; Spaan et al.,
2016)
Utrecht Health Project
(UHP)
2 UniversityMedical
Center Utrecht (The
Netherlands)
10,000 11–19 (Grobbee et al., 2005)
(Continues)
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TABLE 1 (Continued)
Name of Cohort
Number of
subcohorts
includedb
Organizations
(country)
Number of
participantsa
Approx. max
follow-up
duration
(years) for
cancer
diagnosis Reference
Longitudinal Aging Study
Amsterdam (LASA)
1 AmsterdamUniversity
Medical Centers (The
Netherlands)
4632 28 (Hoogendijk et al., 2016;
Huisman et al., 2011)
Netherlands Study of
Depression and Anxiety
(NESDA)
1 AmsterdamUniversity
Medical Centers, on
behalf of the NESDA
consortium
(www.nesda.nl) (The
Netherlands)
2981 15 (Penninx et al., 2008)
Note: In some cohorts ameasurement wave other than baseline is used in PSY-CA due to the absence of ameasure relating to one of the psychosocial factors
outlined in the hypotheses.
aThis is before applying any exclusion criteria (e.g., a history of cancer) and based on baseline adult sample sizes.
bSubcohorts are limited to those that are treated as subcohorts in themeta-analyses. For certain cohorts, subcohorts were combinedwhere subsample sizes
were too small otherwise (i.e.,<1000) and combining resulted inminimal or no loss of data.
TABLE 2 Overview cancer sites considered smoking-related and/or alcohol-related (ICD10 codes)
Both smoking- and alcohol- related cancer sites Smoking-related cancer sites Alcohol-related cancer sites
Tongue (C01) Nasopharynx (C11) Liver and intrahepatic bile ducts (C22)
Other and unspecified parts of the tongue (C02) Stomach (C16) Breast (C50)
Gum (C03) Liver and intrahepatic bile ducts (C22)
Floor of mouth (C04) Pancreas (C25)
Palate (C05) Nasal cavity (C30, excluding
C30.1—middle ear)
Other and unspecified parts of mouth (C06) Accessory sinuses (C31)
Tonsil (C09) Bronchus and lung (C34)
Oropharynx (C10) Cervix uteri (C53)
Piriform sinus (C12) Ovary (C56)
Hypopharynx (C13) Kidney (C64)
Other and ill-defined sites in lip, oral cavity and
pharynx (C14)
Renal pelvis (C65)
Oesophagus (C15) Ureter (C66)
Colorectal (C19-C20) Bladder (C67)
Larynx (C32) Myeloid leukemia (C92)
smoking- or alcohol-related as listed by the International Agency for
Research on Cancer (International Agency for Research on Cancer,
2019) and double-checked by the medical oncologist in the PSY-CA
steering group (AdG; see Table 2). Cancer site is determinedwith codes
from the International Classification of Diseases (ICD) version 10 or
ICD-Oncology version 3 codes for the majority of cohorts, with few
based on ICD version 9 codes. Only the first cancer diagnosis dur-
ing follow-up is considered, and (where available) in situ carcinomas
and neoplasms of undetermined behavior are included as the latter
could be malignant and the former may develop into cancer later if
left untreated. Analyses are also done excluding those with carcinoma
in situ and cancers with undetermined behavior to explore whether
conclusions hold. All studies determine cancer diagnoses through link-
age with national cancer registries, with the exception of CARTa-
GENE and Rotterdam Study. In both these cohorts, other registries
or databases are used to supplement missing information from cancer
registries including hospital visits, insurance claims, and GP records.
The date of cancer diagnosis is considered as the date of cancer inci-
dence. Where cohorts only provided month and year, a fixed date
(15th) is applied for day of diagnosis of cancer. Where cohorts only
provided year of diagnosis, June 30th is assumed to be the date of
diagnosis.
8 of 13 VANTUIJL ET AL.
2.8 Harmonization and data cleaning
Data harmonization ensures the quality of the results, and the inter-
pretability. Harmonization of data across cohorts also enables the use
of standardized scripts for stage 1 analyses (see statistical analysis
below) requiring minimal user input. We apply the Maelstrom guide-
lines (Fortier et al., 2016) to create individual harmonization manuals
for each cohort providing guidance on how to recode data to create
the variables required for PSY-CA. Definitions of the variables to be
derived are agreed upon within the consortium. Local researchers at
each cohort harmonize the data and receive a script to run a number
of basic checks (e.g., checking for proportion ofmissing data). The basic
checks are then reviewed by two researchers (LvT andMB) as an addi-
tional check of adherence to themanuals.
2.8.1 Missing data
Previously defined, cohort-specific approaches to dealing with missing
data is applied within a given measure (e.g., questionnaire). Where no
such approach has previously been defined, the general rule applied is
to substitute person-mean for up to 20%missing responses for a mea-
sure. This rule is basedonprevious studies comparingways todealwith
item-level missing data, specifically in measures of depression (Bono
et al., 2007; Shrive et al., 2006). Missing responses or responses equiv-
alent to “I don’t know” are coded as missing data. The only exception is
the family history of cancer variables where “I don’t know” is coded as
no family history of (the specific) cancer.
2.8.2 Unlikely values and extreme outliers
Local researchers harmonizing the cohort data are instructed to inves-
tigate extreme, unlikely values and recode these to missing if there is
sufficient support that these are errors (e.g., a very high BMI that is
markedly higher than the BMI reported at a follow-up wave for a given
participant).
Across all cohorts, extreme outliers are defined as values that are
more than three times the interquartile range above the third quartile
or below the first quartile, and are truncated to the cut-offs, respec-
tively. The exception to this rule is variables that contain true zeroes
as the lowest possible score as these are likely to be skewed (e.g., pack
years where all never smokers score zero). For these variables, only
the upper extreme values are truncated. The number of cases that are
capped, and the replacement value are recorded for all cohorts and
double-checked.
2.9 Statistical analysis
PSY-CAemploys a two-stage design. In stage 1, local researchers at the
cohort level run a standardized R script over the harmonized dataset,
and subsequently provide all output generated to themain researchers
(LvT, MB, and K-YP). In stage 2, the output from stage 1 across all
cohorts is pooled in the meta-analyses. As such, the main researchers
donot havedirect access to cohort rawdata.However, in the event that
further clarification is required from specific cohort data, subsequent
scripts are sent to the local researchers to gain additional information.
2.9.1 Stage 1
For the analyses related to question one (relationship between psy-
chosocial factors and cancer) and question two (interaction), Cox
regression models are used. For question three (mediation), differ-
ent regression models (logistic and multiple) are used to test the
path between the psychosocial factor and the mediator, dependent
on whether the mediator is categorical or continuous. Cox regression
models are used for the path between the psychosocial factor and can-
cer, and between themediator and cancer.
Across all research questions, entry age is the age at baseline, while
exit age is the age at cancer incidence, death, or endof cancer follow-up
period of the respective cohort (whichever comes first). Note that sev-
eral cohorts are ongoing but, for the purposes of PSY-CA, are capped to
the moment of linkage with the cancer or vitality registry (whichever
comes first). Where another type of cancer occurs (e.g., lung cancer)
after cancer endpoint being modeled (e.g., breast cancer), participants
are censored at the age of first diagnosis (Ji et al., 2020).
For the first two research questions, the followingmodels are run:
Model 1: univariable—which includes the year of birth and the
psychosocial factor.
Model 2: minimum—which additionally adjust for: education
(high, low, with mid-level as reference category) and coun-
try of birth (i.e., whether the participant and [where informa-
tion available] his/her parentswere born in the countrywhere
the cohort is measured). These confounders are available in
all studies with the exception of education in one subcohort
of the HUNT cohort where occupation is used instead (high-
ranking profession, low-ranking profession, with mid-level as
a reference category). Furthermore, in this model we strat-
ify the baseline rates on sex (with the exception of three all-
female studies, and sex-specific cancer endpoints).
Model 3: maximum—which additionally adjust for, where avail-
able, the followingmeasured at baseline:
∙ All cancer outcomes: current anti-depressant use, weekly alcohol
intake, hours of physical activity per week (metabolic equivalent
[MET], if available), body mass index (BMI), pack years, and smok-
ing status (former, current, with never smokers as reference), family
history of cancer (where information about family history of cancer
endpoint are not available, e.g., family history of breast cancerwhere
breast cancer is the endpoint).
∙ Breast cancer outcome: parity (distinguishing between three
or more [full-term] pregnancies, one to two pregnancies, with
zero pregnancies as the reference category), contraceptive use,
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menopause status, age at menarche, and a family history of breast
cancer.
∙ Colorectal cancer outcome: sedentary behavior and family history
of colorectal cancer.
∙ Lung cancer outcome: a family history of lung cancer.
∙ Prostate cancer outcome: a family history of prostate cancer.
Covariates were included where there was nomore than 40%miss-
ing. A number of the variables adjusted for are considered to poten-
tially interact with psychosocial factors for the second research ques-
tion, and as mediators for the third research question. Across all mod-
els, subgroup analyses are conducted by sex. Furthermore, maximum
models are explored where only covariates with no more than 10%
missing are included, and excluding education (which may overcorrect
for the role of health behaviours), and the minimum model is rerun
with the sample of themaximummodel for comparability. All additional
models, subgroup and sensitivity analyses (outlined below in specific
research questions) are considered explorative.
2.9.2 Specifics of research question one
Additional subgroup analyses are conducted based on: cancer stage at
diagnosis (stages 1–2, stages 3–4), age group (younger [18–40], mid
[41–64], and older [65+]). Additional sensitivity analysis is conducted
where borderline or underdetermined cancers and carcinoma in situ
are not considered cancer diagnosis (i.e., not an event), and these par-
ticipants are censored at the moment of this diagnosis. Further sensi-
tivity analysis is conducted where follow-up is capped to 5 years, 10
years, 15 years, and 20 years (where possible). When testing the role
of the psychosocial factors other than depression, an additional model
includes symptoms of depression or depression diagnosis (if available
in the cohort) alongwith all the confounders listed above to explore the
specificity of the psychosocial factor in the risk of cancer. Furthermore,
additional explorative analyses include all psychosocial factors entered
simultaneously in themodel.
2.9.3 Specifics of research question two
Cancer risk factors tested are based on smoking, alcohol use, weight,
physical activity, sedentary behavior, sleep duration and sleep quality,
age, sex, education, hormone replacement therapy, and menopausal
status. Interaction is assessed by first entering the main effects of
the psychosocial factor, the cancer risk factor and an interaction term
between the psychosocial factor and cancer risk factor into the Cox
models outlinedabove, to test formultiplicative interaction. Effect esti-
mates of the psychosocial factor, cancer risk factor, and the interac-
tion term are then used to calculate the relative excess risk due to
interaction (RERI), a measure of additive interaction. Where interac-
tions are significant, interpretation of the interaction effects is derived
as follows: four categories are created (2 [high/low psychosocial fac-
tor] ×2 [high/low cancer risk factor]), and included in the Cox mod-
els outlined above. Further interpretation is derived by estimating the
effect of psychosocial factorswithin subgroupsof the cancer risk factor
(high vs. low cancer risk factor) and estimating the effect of the cancer
risk factor within subgroups based on psychosocial factor (high vs. low
psychosocial factor). Additional subgroup analyses may be explored
depending on the results from research question one.
2.9.4 Specifics of research question three
Mediators tested are smoking, alcohol use, weight, physical activity,
sedentary behavior, sleep duration, and sleep quality. Mediators are
measured at baseline. Three paths are tested in the mediation analy-
ses (for eachmediator): path a (psychosocial factor tomediator), path b
(mediator to cancer incidence), and path c (the direct path from psy-
chosocial factor to cancer incidence while controlling the mediator).
Path a is estimated with linear regression (for continuous mediators)
and (multinomial) logistic regression (for categorical mediators). Cox
regression models are used to estimate paths b and c. The indirect
effect is the product of a × b, the direct effect is c’, and the total effect
is a× b+ c. Additional explorative analyses will be conductedwhere all
mediators are entered simultaneously in the models. Subgroup analy-
sis by sex is conducted. Additional subgroup analysiswill explore differ-
ences in cancer stage at diagnosis (stages 1–2, stages 3–4) specifically
when looking at physical activity as a mediator in prostate cancer. Fur-
ther explorative analysesmay be performedbased on the findings from
research questions one and two.
2.9.5 Stage 2 (meta-analysis)
Random-effects meta-analyses are performed. Cohorts are included in
a given meta-analysis when there are at least 10 cancer events and
the sample size of the cohort (subgroup) is at least 200. Leave-one-out
analyses are conducted to identify influential cohorts. Cohorts are con-
sidered influential if, upon exclusion of the cohort, the between-study
heteogeneity or effect size substantially changes.
Specifically, for question one, the hazards effects (and robust stan-
dard errors) of the psychosocial factors are meta-analyzed. For ques-
tion two, meta-analyses are conducted on hazard effects of the psy-
chosocial factor × cancer risk factor interaction terms (multiplicative
interaction) and on the RERI estimates (additive interaction). In ques-
tion three, overall estimates of all the paths and indirect effect are
obtained by carrying out separate univariate meta-analyses with ran-
dom effects.
Sensitivity analyses will be performed (where at least two stud-
ies with sufficient power are included in the meta-analysis) for
cohorts that determine depression and anxiety through use of clin-
ical interviews. Additional sensitivity analyses are conducted includ-
ing only cohorts that are recruited from the general population.
Finally, moderators of effect size are explored including when the
cohort started, and whether the cohort took place in the Netherlands
or not.
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2.10 Power analysis
To test the power of our IPDmeta-analysis, we ran a power simulation
study similar to that of Ensor et al. (2018), with a focus on depression.
The study information that we used for the simulation study involved
the total number of participants, the prevalence of depression at the
baseline measurement of the study (estimated where this was not yet
known), and the expected number of cancer cases of two types of can-
cer: lung cancer and any cancer (anticipated smallest and largest cate-
gories, respectively). Requiring 80%power, an alpha of 0.05 (two-sided
testing), and using fixed-effects meta-analysis of HR from Cox regres-
sion models, our simulation study showed that regarding main effects
the minimal detectable effect size for is HR = 1.04 for any cancer and
HR= 1.12 for lung cancer.
Regarding the interaction analyses, our calculations (based on the
general convention that the sample size in a single trial should be
increased approximately four times to detect the interaction effect
(Brookes et al., 2004; McClelland & Judd, 1993)) showed that the min-
imal detectable effect size for any cancer is HR = 1.08 for any cancer
and HR = 1.25 for lung cancer. Regarding the mediation analyses, our
calculations (based on an inflation factor of two, compared to testing
the main effects) showed that the corresponding minimal detectable
effect size is HR = 1.06 for any cancer and HR = 1.18 for lung cancer.
The inflation factor of two formediation analysiswas foundas anupper
bound by comparing sample sizes needed for main effects with those
for mediation effects using Baron and Kenny’s test assuming different
effect sizes (Fritz &MacKinnon, 2007).
2.11 Interpretation
The hypotheses tested include four psychosocial factors (depression
[symptoms], anxiety [symptoms], recent loss events, and perceived
social support), four health behaviors (smoking, alcohol, physical activ-
ity, and weight), and seven cancer outcomes (see Appendix 1). It is
important to specify that the interpretation of the results is done holis-
tically, and not based on a single association (i.e., “cherry picking”).
Through triangulation of the evidence from the different analyses, we
conclude if there is statistical support of an association between psy-
chosocial factors and cancer, and by extension whether there is evi-
dence for interaction of or mediation by health behaviors. Interpre-
tation is done by looking at the obtained HRs (or beta-coefficients)
and 95% confidence intervals (CIs) and by exploring consistency and
robustness of the findings. Additionally, the associations between a
number of further psychosocial factors, other health and demographic
factors, and cancer are studied. The results of these additional analyses
are considered to be exploratory. Subgroup and sensitivity analyses are
considered to be exploratory as well.
3 DISCUSSION
Previousmeta-analyses investigating the roleof psychosocial factors in
cancer incidence have shownmixed findings (Chida et al., 2008;McGee
et al., 1994; Oerlemans et al., 2007). While this is partly explained
by differences in the types of psychosocial factors and cancer end-
points, many studies in these meta-analyses pose further limitations,
in particular the absence of adjustment for key confounders. PSY-
CA aims to elucidate the relationship between psychosocial factors
and cancer incidence by employing clearly defined psychosocial fac-
tors measured with reliable instruments. Through harmonization of
the data across cohorts, strict definitions of the psychosocial factors
are applied, thereby increasing interpretability. Furthermore, PSY-CA
considers several different cancer endpoints in addition to any cancer
endpoint, which is crucial given the distinct etiologies of cancers. By
employing two-stage IPD meta-analyses, PSY-CA can address limita-
tions of previous traditional meta-analyses such as adjusting for key
confounders in all cohorts. Therefore, the results from PSY-CA are
more reliable and interpretable.
Given the link of health behaviors such as smoking with both psy-
chosocial factors (Strine et al., 2008; Verger et al., 2009) and cancer
(Biswas et al., 2015; Chen et al., 2018; Kerr et al., 2017), there is a need
to clarifywhether the role of health behaviors ismore than a confound-
ing effect. Health behaviors, demographic and somatic factors that are
well established cancer risk factorsmay interact with psychosocial fac-
tors to pose further risk. Furthermore, health behaviors could explain
the link between psychosocial factors and cancer (i.e., health behaviors
as mediators). Research into the role of health behaviors in the associ-
ation between psychosocial factors and cancer is surprisingly lacking,
and PSY-CA aims to provide insight into this area. As such, the results
from the proposed study outlined in this article may reveal psychoso-
cial factors that put individuals at risk for cancer, identify certain sub-
groups to target with preventive interventions, and support the use of
health-behavior interventions to reduce the risk of cancer associated
with psychosocial factors.
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APPENDIX 1
Specific hypotheses by research questions
Research question 1:Dopsychosocial factors (depression, anxiety, per-
ceived lack of social support, relationship status, recent loss events,
neuroticism, and general distress) increase the incidence of can-
cer? Specifically, we hypothesize that depression, anxiety, recent loss
events, and perceived lack of social support all individually increase the
incidenceof any cancer, breast cancer, lung cancer, prostate cancer, col-
orectal cancer, smoking-related cancers, and alcohol-related cancers.
We limit our hypotheses to depression, anxiety, recent loss events and
perceived low social support given the rather clear distinction between
these concepts (e.g., while neuroticism and general distress are rel-
atively broad constructs incorporating symptoms of both depression
and anxiety), and the focus on these factors in prior research (e.g., rela-
tively little research has looked at relationship status and cancer inci-
dence). Therefore, analyses relating to neuroticism, general distress
and relationship status are considered explorative.
Research question 2: Do these psychosocial factors interact with
health behaviors (smoking, alcohol use,weight, physical activity, seden-
tary behavior, sleep duration, and sleep quality) or demographic and
clinical factors (age, sex, education, hormone replacement therapy, and
menopausal status) on the risk of cancer incidence? Specifically, we
hypothesize that the risk of cancer in people with psychosocial stress
(i.e., elevated depression symptom level or diagnosis, elevated anxi-
ety symptom level or diagnosis, a recent loss event, or perceived lack
of social support) and unhealthy behavior (smoking, alcohol use, over-
weight, and low physical activity) is greater than the sumof the individ-
ual effects of the psychosocial factor and unhealthy behavior on cancer
incidence. We limit our hypotheses to these health-related behaviors
given the consistent evidence of their association with cancer.
Research question 3: Are the relationships between these psy-
chosocial factors and incidence of cancer mediated by health-related
factors (smoking, alcohol use, weight, physical activity, sedentary
behavior, sleepduration, and sleepquality)?Again limiting thehypothe-
ses to depression, anxiety, recent loss events, and perceived low social
support, we hypothesize that (a) smoking, alcohol use, physical inactiv-
ity, and high body mass index (BMI) partially mediate the association
between the psychosocial factors and cancer of any kind, breast can-
cer, and colorectal cancer; (b) smoking partially mediates the associa-
tion between the psychosocial factors and smoking-related cancers; (c)
alcohol use partially mediates the association between the psychoso-
cial factors and alcohol-related cancers; (d) smoking and physical inac-
tivity partially mediate the association between the psychosocial fac-
tors and lung cancer; and (e) physical inactivity partially mediates the
association between the psychosocial factors and prostate cancer.
